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 In order to evaluate the efficacy of herbal drugs, there need to be ways to 
qualitatively and quantitatively determine the constituents and their concentrations in 
various products.  Spilanthes is a popular herbal extract which is used traditionally to 
treat stammering, stomatistis, and throat complaints.  Spilanthes is commonly referred to 
as the “toothache plant,” a name that refers to the analgesic action of its alkylamide 
constituents.  A high performance liquid chromatography/electrospray ionization mass 
spectrometry (HPLC/ESI-MS) method was developed to evaluate the quantity, identity, 
and stability of the alkylamides in ethanolic extracts of Spilanthes acmella.  The 
developed method was then subjected to method validation according to guidelines given 
by the International Committee of Harmonisation (ICH) section Q2 (R1).  The linear 
dynamic range for the method was determined to be 0.45 µM – 450 µM.  The method 
detection limit and quantitation limit were estimated at 0.27 µM and 0.45 µM, 
respectively.  The method precision was evaluated on two levels: repeatability and 
intermediate precision and was 6% or less.  The method proves valuable for the 
quantitation and identification of the alkylamide spilanthol in S. acmella.  Eight 
additional alkylamides have been tentatively identified (based on molecular weight and 
fragmentation patterns) in a 75% ethanol extract of S. acmella.  The structure of the most 
abundant of these alkylamides, (2E,6Z,8E)-N-isobutyl-2,6,8-decatrienamide, spilanthol, 
 
 
was confirmed by NMR.  The spilanthol concentration in the extract shows no significant 
degradation during storage over six and a half months at room temperature, -20°C, and  
-80°C.  Spilanthes extract and isolated spilanthol showed no antibacterial activity against 
Staphylococcus aureus. 
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CHAPTER I 
 
 
INTRODUCTION 
 
 
 
The proof of efficacy of herbal drugs has been a topic of controversy and debate in 
the medical community for several decades.1  The value of double-blind, randomized, 
controlled studies to prove efficacy of herbal drugs has not completely gained full 
support by the medical community, although it has not yet been entirely abandoned.1  In 
order to obtain reproducible results from such trials, it is necessary to establish a 
chemical standardization of the extract preparation.2  To facilitate this standardization, 
there must be ways to qualitatively and quantitatively determine constituents and their 
concentrations in various extracts.  It is also necessary to know which constituents are 
important in the biological activity of the extract.  Thus, clinical trials and in vitro 
research concerning biological activity go hand in hand with chemical analysis; it is not 
possible to know which constituents are important without knowing which constituents 
are in the products being tested for efficacy. 
Constituents and Therapeutic Use of Spilanthes acmella 
A popular herbal preparation, Spilanthes, is used traditionally to treat mouth aliments, 
stammering, stomatistis, and throat complaints.3  Several studies have demonstrated 
biological activity of Spilanthes species.  Ratnasooriya and Pieris demonstrated that cold 
water extracts of the flowers of Spilanthes acmella possess antinociception activity 
 
2 
against persistent pain and antihyperalgesic activity.4  Sukumaran and Kuttan observed 
chloroform extracts of S. calva inhibited tobacco induced mutagenesis on Salmonella 
typhimurium.5   
Spilanthes’ biological activity has primarily been attributed to constituents known as 
alkylamides, which this plant possesses in abundance.  Alkylamides from Spilanthes have 
demonstrated strong diuretic6 and insecticidal properties,7 and alkylamides from other 
plants (specifically Echinacea species) have demonstrated in vitro8, 9 and in vivo10 
immunomodulatory activity.  Today, alkylamide containing extracts of Spilanthes are 
sold as dietary supplements by a number of herbal extract manufacturers, and the 
biological activity of these extracts and their constituents is an ongoing subject of 
research.  Validated methods for analysis of alkylamides in complex Spilanthes extracts 
are needed to facilitate this research and to serve as the basis for quality control of 
commercial Spilanthes products.   
Spilanthes is a native plant of the tropics of Africa and South America with yellow 
flower heads.  Spilanthes is commonly referred to as the “toothache plant,” a name that 
refers to the analgesic action of the alkylamide constituents.  The species of interest in 
this research is Spilanthes acmella which is also known as Acmella oleracea and 
Spilanthes oleracea.   
Alkylamide constituents are restricted to four families in the botanical kingdom.11  
Alkylamides with unsaturated acid residues can be classified as purely olefinic or 
acetylenic, which possess both olefinic and acetylenic linkages.12  Purely olefinic 
alkylamides have been isolated from the four families, but the acetylenic alkylamides 
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have only been isolated from one family, Asteraceae.12  Within the Asteraceae family, 
the purely acetylenic alkylamides are restricted to two tribes: Anthemideae and 
Heliantheae.12  Both types of alkylamides have been reported from genera belonging to 
the Heliantheae tribe, such as Heliopsis,13, 14 Echinacea,8, 15-17 and Spilanthes. 3, 11, 13, 14, 18-
25  The research presented here focuses on the chemical analysis of Spilanthes (family: 
Asteraceae, tribe: Heliantheae, subtribe: Ecliptinae.)11   
Previously Published Methods for Analysis of Alkylamides from Spilanthes 
Alkylamides have previously been detected in Spilanthes.3, 11, 14, 20-26  However, there 
is relatively little research published on the identification of alkylamides in S. acmella, 
and no method exists for their quantification.  Although there is currently no literature 
report of the quantitative analysis of alkylamides from Spilanthes, Nagashima and 
Nakatani used NMR spectroscopy and HPLC-MS with atmospheric pressure chemical 
ionization11 and electron impact ionization3 to determine structure of pungent 
alkylamides in extracts of S. acmella.  They identified nine alkylamides, the most 
abundant of which was determined to be (2E,6Z,8E)-N-isobutyl-2,6,8-dectrienamide or 
spilanthol.  Alkylamides have also been identified in several other species of Spilanthes 
including: S. americana,25 S. oppositifolia,26 S. ocymifolia, 20 S.ciliata,22, 23 and S. 
mauritiana.21  These studies demonstrate that an array of different alkylamides are 
present in Spilanthes, but none of them provide an approach for quantitatively evaluating 
alkylamide content of Spilanthes extracts.   
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Research Objectives 
Our objectives in these studies were to evaluate the quantity, identity, and stability of 
the alkylamides in ethanolic extracts of Spilanthes acmella.  To accomplish these 
objectives, we developed and validated a novel method for analysis of Spilanthes’ 
alkylamides using HPLC coupled to electrospray ionization mass spectrometry (ESI-
MS).  This method demonstrates the power of HPLC/ESI-MS for both quantification and 
identification of plant constituents.  In addition, the method described here will facilitate 
further assessment of the therapeutic potential of Spilanthes by providing an approach to 
monitor constituent concentration in extracts used for in vitro or in vivo studies.  Finally, 
data indicating the stability of spilanthol in ethanolic extracts stored under various 
conditions is presented. 
Overview of Techniques Used in this Research 
The major analytical technique used in these studies is reversed-phase high-
performance liquid chromatography coupled to electrospray ionization mass spectrometry 
(HPLC-ESI-MS) or reversed-phase high-performance liquid chromatography with UV 
photodiode array spectrophotometric detection (HPLC-PDA).  HPLC is a 
chromatographic technique in which analyte resolution occurs when the components of 
the solution interact to different extents with the stationary phase.27  In reversed phase 
HPLC, the stationary phase is non-polar and the mobile phase is polar.  In this research, a 
column with a C18 alkyl group bonded to the silica surface is used, which constitutes a 
non-polar stationary phase.  Separation of mixture components occurs based on their 
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relative attraction to the stationary (non-polar) phase with the most polar analytes eluting 
more rapidly than the less polar ones.27   
We utilized preparatory scale HPLC-PDA to isolate the spilanthol standard.  The use 
of the PDA detector allows the column effluent to be monitored for the analyte of interest 
based on its absorbance.  For these experiments, the wavelength monitored was 254 nm, 
in the UV region.  Alkylamides are able to absorb UV light due to the conjugated pi 
system of electrons along their unsaturated alkyl chains (see alkylamide structures in 
Figure 20).  However, the use of the PDA detector provides very little structural 
information about analytes; therefore, additional methods of detection are needed for 
structural elucidation.   
For identification and quantification experiments, the HPLC/ESI-MS is used.  In this 
technique, the column effluent is directly interfaced to the ion trap mass spectrometer.  
Electrospray ionization used in this research accomplishes ionization from solution and is 
carried out at atmospheric pressure.  The column effluent is passed through a metal 
capillary held at a high voltage in order to separate charged analyte molecules from their 
counter ions.27  The solution protruding from the capillary becomes highly charged, and 
the coulombic repulsion of like charged ions eventually overcomes the surface tension of 
the solution and causes it to break up into a mist of highly charged droplets.27  These 
droplets then undergo desolvation aided by drying gas (nitrogen) until the repulsive 
forces of the charges again exceed the cohesive forces of surface tension.  At this point 
the droplet then fissions into a series of smaller droplets by a process known as a 
“coulombic explosion.”27  The droplets undergo these “coulombic explosions” until free 
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analyte ions are produced.  These ions are then directed into the mass spectrometer 
through a series of focusing lenses.  The ions are “held” in the ion trap, which consists of 
three hyperbolic electrodes.  Two of these electrodes are endcaps and the third is a 
doughnut shaped ring electrode.28  The “trap” contains helium gas at a pressure of 
typically, 1 mTorr, which reduces the kinetic energy of the ions trapped, thereby, 
contracting their trajectories toward the center of the trap.27  These ions will remain in the 
trap until a RF voltage is applied to the ring electrode.  This RF voltage makes the 
trajectory of ions with a particular m/z unstable and causes them to be ejected from the 
trap.27  A complete mass spectrum can be obtained by varying the RF voltage in a 
systematic way so as to sequentially eject ions of increasing m/z from the trap.  The mass 
spectra obtained with positive ion ESI-MS consist primarily of the protonated molecular 
ions (MH+) of constituents of the solution.  Salt clusters can also be detected, as can 
deprotonated species in the negative ion mode.  ESI is a soft ionization technique, 
therefore, it causes little fragmentation and identification of the molecular ion is usually 
possible.  This facilitates determination of the mass of the analyte of interest, which is a 
key element in the process of identification, but additional information is still necessary 
to obtain a positive identification of the analyte of interest. 
Further structural elucidation and conformation of identity can be achieved by tandem 
mass spectrometry (MS-MS) analysis.  A MS-MS spectrum is obtained by selecting and 
fragmenting the molecular ion of interest.  The resulting scan gives a mass spectrum of 
the product ions produced from the decomposition of the molecular ion.  In MS-MS 
analysis utilizing an ion trap mass spectrometer, the ion of interest is held in the trap 
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while all other ions are ejected.  The isolated ion is then fragmented by collisionally 
activated dissociation due to interaction with excited helium gas in the trap.  The 
resulting fragments are then ejected from the trap by varying the RF voltage, giving rise 
to a MS-MS (fragmentation) spectrum.  For this research, data dependent MS-MS was 
used.  Using data dependent MS-MS, the most abundant ion that elutes from the HPLC 
column at a given time can be trapped and fragmented, producing a MS-MS spectrum.  If 
the precursor ions of interest are known, a list of ions of interest can be generated, so that 
the most abundant ion detected from the list at any given time will be subjected to MS-
MS analysis.  The MS-MS spectrum obtained can be utilized to confirm or determine the 
structure of the compound of interest.  However, even though a great deal of information 
can be obtained from MS-MS spectra, the stereochemistry of the molecule can not be 
determined.  In order to positively assign stereochemistry and compound structure, 
complementary techniques such as nuclear magnetic resonance (NMR) spectroscopy are 
essential.   
NMR spectroscopy enables elucidation of the carbon backbone of an organic 
molecule and the environments of the hydrogens attached.29  For this research both 1H-
NMR and 13C-NMR were utilized.  NMR spectrometers measure the amount of energy 
absorbed by a nucleus of an atom when it is excited from its lowest energy spin state to 
the next higher one.29  For 1H-NMR, the amount of energy absorbed by the proton’s 
nucleus is influenced by neighboring electrons, the more electrons the more shielded the 
proton and hence, the more energy required to flip its spin.  This variation in energy 
absorbed gives rise to chemical shifts which can be different for various protons in a 
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molecule and are characteristic of particular structural features.29  As with electrons 
influencing the energy absorbed by protons, the magnetic field of different types of 
protons can also influence each other resulting in spin-spin splitting.  By calculating the 
separation between adjacent lines in a signal, referred to as the coupling constant, the 
position ( i.e. cis or trans) of the hydrogens to one another can be determine.  13C-NMR 
works essentially the same way except there is no spin-spin splitting observed.  13C-NMR 
enables the determination of the magnetic environment of the carbon atoms in the 
molecule.  These carbon atoms are also prone to shielding by neighboring electrons; 
however, these effects are much greater for carbon than for the protons because they are 
directly connected to the neighboring carbon.  By evaluating the chemical shifts of the 
carbon atoms, their connectivity can be discerned and, hence, the backbone of the 
molecule can be determined.   
Method Validation 
The HPLC/ESI-MS method developed and used to quantify alkylamides in ethanolic 
extracts of S. acmella was validated according to guidelines given by the International 
Committee of Harmonisation (ICH) section Q2 (R1.)30  The aspects investigated were 
linearity, range, precision [a) repeatability, b) intermediate precision], and limits of 
detection and quantification.   
Linearity of an analytical procedure is the concentration range in which the analyte 
response is directly proportional to the concentration of the analyte in the sample.  The 
working range of the method is determined by confirming that the method provides an 
acceptable degree of linearity and precision for a range of standard concentrations.30  
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Both the linearity and range are determined by evaluating a range of concentrations of a 
standard of the analyte of interest.   
The closeness of agreement (degree of scatter) between a series of measurements 
obtained from sampling the same sample under the same conditions is expressed as the 
precision of an analytical method.30  The method precision was considered at two levels: 
repeatability and intermediate precision.  Precision is expressed as the standard deviation 
of a series of measurements.  Repeatability evaluates precision of samplings under the 
same conditions over a short interval of time.  The effects of random events on the 
analytical procedure are evaluated with intermediate precision.  Intermediate precision is 
determined similarly to the repeatability, but the analysis is conducted on data collected 
over multiple days.  The standard deviation and relative standard deviation are then 
determined from collected data.   
The least amount of analyte in a sample which can be detected but not necessarily 
quantified as an exact value is the limit of detection (LOD) of an analytical procedure.30  
The detection limit can be determined by several approaches such as: visual inspection, 
signal-to-noise, standard deviation of the response and the slope, and calibration curve.  
The smallest amount of analyte in a sample that can be reliably and accurately quantified 
is the limit of quantitation (LOQ) for an analytical procedure.30  The same approaches 
used for LOD determination (visual inspection, signal-to-noise, standard deviation of the 
response and the slope, and calibration curve) can be used to determine LOQ. 
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Antibacterial Assay 
A recent study investigating the antifungal potential of flower head extract of S. 
acmella showed that the extract possesses fungi toxic activity against potential human 
pathogens Asperigillus niger and A. paraciticus, and agricultural pathogens Fusarium 
oxysporium and F. moniliformis.31  In another study, chloroform, methanol, and aqueous 
extracts of various plants including Spilanthes were tested for antibacterial activity 
against important pathogenic bacteria including Staphylococcus aureus.  Only the 
chloroform extract showed any antibacterial activity, and that extract was only toxic to 
Streptococcus mutans.32  In an ethnopharmacological survey, extracts of six East African 
medicinal plants including Spilanthes mauritiana were tested against 105 strains of 
bacteria.  The minimum inhibitory concentration and minimum bactericidal 
concentrations were determined to be > 8mg/mL for the methanolic extracts of S. 
mauritiana, which indicates low antibacterial activity.33  However, the compounds 
responsible for the antifungal or antibacterial activity seen were not specified.  One of our 
goals in the studies described here is to evaluate antibacterial activity of isolated 
alkylamides from S. acmella, including spilanthol, as well as complex S. acmella 
extracts.  This should show if any antibacterial activity observed is due solely to the 
alkylamides or if it is due to a combined effect with other constituents in the extracts.  
The complex extract and isolated spilanthol will also be tested in combination with 
berberine to see if constituents of S. acmella have multidrug resistance pump inhibitory 
activity.34  
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CHAPTER II 
 
 
EXPERIMENTAL 
 
 
 
Preparation and Storage of Extracts  
Fresh whole plants of S. acmella were extracted using a range of ethanol 
concentrations.  The extraction was accomplished by blending the plants in the 
appropriate solvent (0, 10, 25, 50, 75, or 95% ethanol) at a ratio of 2 mL solvent: 1g plant 
material.  The extracts were then allowed to macerate for 14 days at ~4°C and the solvent 
was removed using a hydraulic press.  These extracts were stored at -20°C.  From the 
95% ethanol extract, the spilanthol standard used to validate the HPLC/ESI-MS method 
was isolated. 
In order to study the stability of spilanthol in a S. acmella extract, fresh whole 
plants of S. acmella were obtained from Horizon Herbs (Williams, OR) and a voucher 
specimen was pressed and stored.  The fresh plant was washed thoroughly and weighed 
to the nearest 1 g.  A total of 577 g plant material was used.  The solvent used for the 
extraction consisted of 75% ethanol and 25% water.  This extraction solvent was 
prepared by making a mixture consisting of 21% water (purified with a Barnstead 
Nanopure Diamond, D11931, Barnstead International, Dubuque, IA) and 79% ethyl 
alcohol USP (190 proof, 95 % ethanol, AAPER Alcohol and Chemical Co., Shelbyville, 
KT.)  A 2:1 extract (2 mL solvent: 1 g plant material) was prepared with a final ethanol 
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content of 60% (accounting for water from the plant material as well as the solvent.)  The 
plant material and solvent were thoroughly blended using a commercial blender (Waring 
Commercial 51BL30, Torrington, CT) and allowed to macerate for a period of 7 days.  
The extract was then expressed from the plant using a hydraulic press and filtered under 
vacuum with a 0.2 µm nylon filter to remove any particulates.  Three aliquots of the 
extract (10 mL in 15-mL polypropylene tubes, Fisher Scientific, Pittsburgh, PA) were 
stored at each of the following conditions -80°C, -20°C, and room temperature.  The 
remaining extract was stored at -20°C.   
Solid Phase Extraction 
The lipophilic alkylamides in the 95% ethanol extract were separated from the 
hydrophilic plant matrix by SPE using an eluent ethanol content from 45 to 100%.  
Twelve fractions were collected overall.  These fractions were analyzed by HPLC/ESI-
MS to confirm presence of and tentatively identify possible alkylamides.   
Analysis of Extracts with HPLC/ESI-MS 
Analyses of spilanthol content were carried out with reversed phase HPLC 
coupled to ESI-MS.  An HP1100 (Agilent, Palo Alto, CA) HPLC system was used for the 
separation.  The chromatographic column used was a short, narrow bore C18 column (50 
mm x 2.1 mm, 3 µm particle size, 110 Å pore size, Prevail packing, Alltech, Deerfield, 
IL) equipped with a 0.5 µm precolumn filter (MacMod Analytical, Chadds Ford, PA).  
An isocratic separation was conducted with mobile phase composition of 50% A and 
50% B (where A = 1% acetic acid in nanopure water and B = HPLC grade acetonitrile).  
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A flow rate of 0.2 mL/min was used, the injection volume was 10 µL, and the total 
analysis time was 22 min.   
The outlet of the HPLC column was connected directly to an ion trap mass 
spectrometer (LCQ Advantage, Thermo Finnigan, San Jose, CA).  Mass spectrometric 
detection was carried out in the positive ion mode with a scan range of 100 -1000 m/z.  
The mass spectrometer was operated with the following parameters: a capillary 
temperature of 275°C, a sheath gas pressure of 20 arb, and spray, capillary, and tube lens 
voltages of 4.5 kV, 3 V, and 60 V, respectively.   
Isolation of Spilanthol 
The standard used to quantify and validate the HPLC/ESI-MS method was isolated 
from a 95% ethanol S. acmella extract using preparatory scale HPLC-PDA with fraction 
collection.  SPE was used to remove the hydrophilic compounds from a 50 mL aliquot 
(diluted to 100 mL with deionized water) of the 95% ethanolic extract of S. acmella.  The 
lipophilic alkylamides eluted with 100 mL of a 95% ethanol solution.  The solvent from 
12 mL of the SPE fraction was removed under vacuum and reconstituted in 2 mL of 95% 
ethanol.  The reconstituted sample was used for HPLC-PDA fraction collection to obtain 
isolated spilanthol.  An HPLC HP1100 (Agilent, Palo Alto, CA) with a UV/VIS 
photodiode array detector and a Haisil 100 C18 column (150 mm x 100 mm, 5µm 
particle size, 100 Å pore size, Higgins Analytical, Mountain View, CA) was used.  The 
injection volume was 500 µL and the flow rate was 2.0 mL/min.  The separation was 
accomplished isocratically using the same solvent composition described above.  
Absorbance was monitored at 254 nm, and a peak that eluted at 16.0 min was collected.  
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The collected fractions from five separations were combined in a pre-weighed centrifuge 
tube and the solvent was removed under vacuum to determine dry weight.  The sample 
was then re-dissolved in ethanol at a concentration of 1.0 mg/mL (4.5 x 10-3 M) to make 
the stock standard solution of spilanthol.   
Purity of Spilanthol Standard 
The purity of the solution was estimated by HPLC/ESI-MS and HPLC-PDA by 
calculating the % peak area in the chromatogram corresponding to spilanthol.  The purity 
of the spilanthol peak obtained using HPLC-PDA was also evaluated by observing the 
absorbance spectra obtained at multiple points across the peak.  If the peak is due to one 
compound then the absorbance spectra should be identical across the peak.   
Quantification and Stability of Spilanthol in Ethanolic Extracts  
The stock solution of spilanthol (isolated from S. acmella as described above) was 
serially diluted to make five standards at concentrations of 1.4 µM, 4.5 µM, 14 µM, 45 
µM, and 140 µM.  The calibration standards were analyzed using HPLC/ESI-MS as 
described earlier.  A calibration was generated by plotting the log of the sum of the peak 
areas of the selected ion chromatograms for the spilanthol ions versus the log of the 
concentration.  Because spilanthol forms a dimer in the gas phase, the peak area for m/z 
443 (proton bound dimer) was doubled and added to the peak area of m/z 222 (protonated 
molecular ion) to account for all of the spilanthol response. 
The replicate extract samples stored under various conditions were also analyzed by 
HPLC/ESI-MS.  Prior to analysis, an aliquot (4 µL) of each extract was diluted to 1.5 mL 
in 95% ethanol to provide a sample within the linear range of the calibration curve.  The 
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samples were analyzed at various time points to monitor degradation of spilanthol.  For 
each analysis, calibration standards were analyzed in the same run with the samples to 
minimize errors due to day-to-day variability in instrument response.   
Identification of Alkylamides 
Tentative identification of eight alkylamides was achieved by comparison of 
molecular ions and MS-MS fragmentation patterns.  The molecular ion values were 
compared to literature values.3, 11  The MS-MS fragmentation patterns obtained with 
HPLC/ESI-MS and activated dissociation in the ion trap with a collision energy of 35% 
were compared to expected fragmentation of alkylamides.35   
The MS-MS spectra for the alkylamides were obtained by utilizing a data dependent 
scan (Xcalibur ver. 1.4 SR1) and collisionally induced dissociation (CID) within the ion 
trap of the mass spectrometer.  A list of precursor ions was chosen for the data dependent 
scan based on published masses of alkylamides and consisted of the following m/z 
values: 204, 232, 222, 246, 258, 236, 260, 230, 248, 252, and 268.  Two analyses of the 
S. acmella extract were conducted using this list of ions, one in which the most intense 
ion from the list was fragmented at any given time, and one in which the MS-MS scan 
was collected for the second most intense ion from the list.  This approach facilitated 
collection of MS-MS spectra for both the major and minor alkylamides present in the 
extract.   
Positive identification of spilanthol was confirmed based on the mass of the 
molecular ion, its MS-MS fragmentation pattern, its absorption maxima (λmax) and 
spectrum, and comparison of 1H-NMR and 13C-NMR shifts to literature values.11, 35  For 
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NMR analysis, a 3.4 mg of purified spilanthol was dissolved in 700µL of CDCl3 and 
analyzed on a Jeol ECA 500MHz NMR spectrometer (Peabody, MA, USA.)  A 10 
mg/mL spilanthol standard was analyzed by HPLC-PDA as described earlier to obtain an 
absorption maxima and spectrum. 
Method Validation 
Linearity was determined initially by visual inspection of a calibration curve 
covering a large concentration range.  Once a preliminary linear range was determined, 
five concentrations encompassing the range were analyzed in triplicate.  A regression line 
was calculated by method of least squares on the linear portion of the calibration curve.  
The correlation coefficient, y-intercept and slope of regression line were then evaluated.   
The external standard calibration method was employed on five standard solutions 
analyzed in triplicate.  A calibration curve was constructed by plotting the log of the sum 
of corresponding peak areas of the selected ion chromatograms versus log of analyte 
concentration.  The mean peak area from triplicate analyses of each sample was used to 
construct this curve.  A regression line was calculated by method of least squares on the 
linear portion of the calibration curve to determine linearity. 
The S. acmella standards were used to determine linear dynamic range, 
repeatability, and intermediate precision.  The linear dynamic range was determined by 
analyzing standards ranging from 0.23 µM to 1400 µM in triplicate and plotting a 
calibration curve.  The concentrations that gave a linear regression line and acceptable 
precision were used as a measure of the range.  Repeatability was evaluated by analyzing 
the five spilanthol standards in triplicate and determining the standard deviation and 
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relative standard deviation of the back calculated concentration for those triplicate 
analyses.  Intermediate precision was evaluated by analyzing the five standards in 
triplicate over a period of three days.  The standard deviation and relative standard 
deviation for the intermediate precision were calculated using the average back calculated 
concentration for each of the three days for each standard concentration. 
The approach that was utilized for determination of LOD and LOQ for these 
analyses was based on signal-to-noise because the HPLC/ESI-MS exhibits baseline noise.  
The signal-to-noise ratio was determined by comparing measured signals from samples 
with low analyte concentrations with those of a blank sample.  The LOD was determined 
as the concentration that would give a signal-to-noise ratio of 3:1 and the LOQ was the 
concentration calculated to give signal-to-noise ratio of 10:1.   
Antibacterial Assay 
The antibacterial activity was tested by the agar diffusion method with top agar.  
Sterile filter paper disks (Whatman no. 41; 9 cm in diameter) were soaked with 10µL of 
sample and allowed to air dry.  The complex S. acmella extract and isolated spilanthol 
were tested.  The complex extract was a 75% ethanolic extract of fresh whole plants of S. 
acmella and was also concentrated 10 fold and analyzed.  The concentrations of the 
isolated spilanthol tested were 1, 5, or 10 mg spilanthol per mL of ethanol.  All samples 
were also tested in combination with 5µg/mL berberine (Sigma) to see if they had 
multidrug resistance pump inhibitory activity.34  Disks were applied onto the surface of 
1.5% Bacto ™ agar plates topped with a layer of 0.75% Bacto ™ agar seeded with a 24 
hour culture of Staphylococcus aureus in Muller Hinton Broth (Fisher).  The plates were 
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incubated at 37°C for 24 hours.  A 30µg kanamycin (Fisher) antibiotic disk was used as a 
positive control.  The antibacterial activity was evaluated by measuring the inhibition 
zone formed around the disk.  
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CHAPTER III 
 
 
RESULTS AND DISCUSSION 
 
 
 
Solid Phase Extraction 
The results of SPE showed that the alkylamides eluted in fractions 2 through 11 
with an eluent ethanol content of 45% to 60%.  None of the fractions showed complete 
separation of the molecular ion with an m/z 222, spilanthol, from the other possible 
alkylamides present, and further purification with HPLC-PDA with fraction collection 
was employed.  Figures 1-10 show the base peak chromatograms obtained using 
HPLC/ESI-MS for the SPE fractions 2-11 of S. acmella.  For all the SPE figures, the top 
chromatogram represents the entire time period, while the lower chromatogram is an 
enlargement of the possible alkylamides.  Table 1 summarizes the molecular ion m/z of 
the alkylamide and the fraction in which it elutes.   
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Table 1: Summary of SPE fraction contents. 
 
 
SPE Fraction MH+ (m/z) 
2 204, 268, 230, 232 
3 268, 230, 232, 222 (spilanthol) 
4 230, 232, 443 (proton bound dimer of spilanthol) 
5 443, 236 
6 222, 236 
7 222, 236, 248 
8 222, 236 
9 236 
10 236 
11 236, 248 
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Figure 1: a) Base peak chromatogram of SPE fraction 2 of S. acmella obtained using 
HPLC/ESI-MS, b) base peak chromatogram zoomed in on peaks of interest from 
time 2.5-8 min. 
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Figure 2: a) Base peak chromatogram of SPE fraction 3 of S. acmella obtained using 
HPLC/ESI-MS, b) base peak chromatogram zoomed in on peaks of interest from 
time 3.5-11 min. 
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Figure 3: a) Base peak chromatogram of SPE fraction 4 of S. acmella obtained using 
HPLC/ESI-MS, b) base peak chromatogram zoomed in on peaks of interest from 
time 3.5-10 min. 
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Figure 4: a) Base peak chromatogram of SPE fraction 5 of S. acmella obtained using 
HPLC/ESI-MS, b) base peak chromatogram zoomed in on peaks of interest from 
time 4-13 min. 
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Figure 5: a) Base peak chromatogram of SPE fraction 6 of S. acmella obtained using 
HPLC/ESI-MS, b) base peak chromatogram zoomed in on peaks of interest from 
time 4-16 min. 
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Figure 6: a) Base peak chromatogram of SPE fraction 7 of S. acmella obtained using 
HPLC/ESI-MS, b) base peak chromatogram zoomed in on peaks of interest from 
time 5-15 min. 
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Figure 7: a) Base peak chromatogram of SPE fraction 8 of S. acmella obtained using 
HPLC/ESI-MS, b) base peak chromatogram zoomed in on peaks of interest from 
time 5-16 min. 
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Figure 8: a) Base peak chromatogram of SPE fraction 9 of S. acmella obtained using 
HPLC/ESI-MS, b) base peak chromatogram zoomed in on peaks of interest from 
time 5-17 min. 
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Figure 9: a) Base peak chromatogram of SPE fraction 10 of S. acmella obtained 
using HPLC/ESI-MS, b) base peak chromatogram zoomed in on peaks of interest 
from time 6-18 min. 
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Figure 10: a) Base peak chromatogram of SPE fraction 11 of S. acmella obtained 
using HPLC/ESI-MS, b) base peak chromatogram zoomed in on peaks of interest 
from time 6-18 min. 
 
 
 
Isolation of Spilanthol 
  The SPE method did not afford isolated spilanthol, so HPLC-PDA with fraction 
collection was employed to obtain a more highly purified sample.  Figure 11 shows a 
representative chromatogram of the SPE fraction used for peak collection.  The peak that 
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eluted at 16.0 minutes was collected and the solvent removed under vacuum to afford 
isolated spilanthol.  
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Figure 11: HPLC chromatogram of SPE fraction used for peak collection to isolated 
spilanthol generated using HPLC with photodiode array spectrophotometric 
detection. 
 
 
 
Purity of Spilanthol Standard 
The purity of the isolated spilanthol solution was estimated by HPLC-PDA and 
HPLC/ESI-MS.  Figure 12 shows a blank (ethanol) chromatogram and a spilanthol 
standard chromatogram obtained using HPLC-PDA.  There are no co-eluting peaks with 
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spilanthol peak.  The purity of the spilanthol solution was estimated to be 97% using 
HPLC-PDA.   
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Figure 12: HPLC chromatograms of a) ethanol blank and b) spilanthol standard 
generated using HPLC with photodiode array spectrophotometric detection.  
 
 
 
Figure 13 shows the base peak chromatograms for an ethanol blank (top) and a 
spilanthol standard (bottom) obtained using HPLC/ESI-MS.  There appears to be no co-
eluting peak with spilanthol, however, there are a few peaks corresponding to impurities.  
The purity of the spilanthol solution was estimated to be 88% using HPLC/ESI-MS. 
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Figure 13: Base peak chromatogram of a) ethanol blank and b) spilanthol standard 
generated using HPLC/ESI-MS. 
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Figure 14: a) Chromatogram of spilanthol showing points where UV-VIS spectra 
were acquired.  b) UV/VIS absorbance spectra overlaid for spilanthol peak. 
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Quantification and Stability of Spilanthol in Ethanolic Extracts  
The HPLC/ESI-MS method was employed to compare concentrations of 
alkylamides in extracts prepared from fresh whole plants of S. acmella using a range of 
ethanol concentrations for extraction.  The spilanthol content was observed to increase 
with increasing ethanol concentration in the extraction solvent, and the most concentrated 
extract had a spilanthol concentration of (7 ± 1) x 102 µg/mL.  Figure 15 shows the 
spilanthol content of the extracts analyzed. 
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Figure 15: Spilanthol concentration in ethanolic extracts of S. acmella.  Error bars 
represent +/- standard deviation which was calculated using linear regression. 
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The HPLC/ESI method was also employed to evaluate the stability of spilanthol 
in a 75% ethanolic extract of S. acmella over a period of six and a half months.  Results 
of the stability study are shown in Figure 16.  Data points represent the average of one 
injection of three replicate samples for each storage condition.  The diamonds, squares, 
and triangles represent the three storage conditions, room temperature, -20°C, and -80°C 
respectively. 
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Figure 16: Concentration of spilanthol in 75% EtOH extracts of S. acmella stored 
for various lengths of time under various conditions.  Data points represent the 
average of one injection of three replicate samples for each storage condition.  The 
diamonds, squares, and triangles represent the three storage conditions, room 
temperature, -20°C, and -80°C respectively. 
 
 
 
At the end of a six and a half month stability study, there appears to be no clear 
trend toward degradation in the concentration of spilanthol in the extracts at any 
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temperature.  The closeness of all temperature replicates may indicate that the variation 
observed is most likely due to variations in instrument response over the time period 
evaluated rather than actual degradation in spilanthol.  It should be noted that the data 
were all based on separate calibration curves run on the day of analysis.  Absolute 
instrument response changes over time (due to a number of factors including fouling of 
the internal components of the instrument and drift in electronic components); therefore, 
in order to achieve acceptable intermediate precision, calibration curves should be 
included in the same run with the samples. 
Identification of Alkylamides 
The most abundant alkylamide identified in the ethanolic extract of S. acmella has a 
mass which corresponds to the protonated molecular ion of (2E,6Z,8E)-N-isobutyl-2,6,8-
dectrienamide, or spilanthol, a known constituent of S. acmella.11  The identity of the 
compound as spilanthol was confirmed by HPLC/ESI-MS-MS fragmentation, 1H-NMR, 
and 13C-NMR.  The MS-MS fragments (obtained with collisionally activated dissociation 
in the ion trap) and UV absorption spectrum for spilanthol are shown in Figures 17 and 
18, respectively.  A λmax value (wavelength of maximum absorbance) of 229 nm was 
observed, which is consistent the published value for spilanthol.11 
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Figure 17: MS-MS spectrum obtained by activated dissociation with a collision 
energy of 35% of protonated molecular ion for spilanthol at m/z 222.  The structure 
of protonated spilanthol with assignment of fragments is also shown. 
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     Wavelength (nm) 
 
 
Figure 18: UV-VIS absorbance spectrum for spilanthol showing a λmax of 229nm.  
This spectrum was obtained for the peak at 16.0 min. using the PDA detector of the 
HP1100 HPLC.   
 
 
Ten additional alkylamides were tentatively identified in the ethanolic extract of S. 
acmella by comparison of molecular ion masses with molecular weights published for 
previously identified alkylamides.  The selected ion chromatograms for the molecular 
ions of each of these compounds as well as spilanthol in the complex Spilanthes acmella 
extract are shown in Figure 19 and tentative structures can be seen in Figure 20.   
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Figure 19: Selected ion chromatograms for molecular ions of tentatively identified 
alkylamides present in the complex S. acmella extract. 
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Figure 20: Structures of alkylamides tentatively identified in the ethanolic extract of 
S. acmella.  Compound 3 was confirmed with NMR, compounds 1,2 and 4-9 were 
confirmed with MS-MS and compounds 10 and 11 were assigned based on 
molecular weight alone.  
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The structural assignments of the alkylamides seen above are listed in Table 2 and 
most are only tentative because, except in the case of compound 3 (spilanthol), they were 
not confirmed with NMR.  However, comparisons of molecular ion masses were made 
with molecular weights published for previously identified alkylamides, whose structures 
had been eludicated based on NMR data in previous investigations.11   
 
 
Table 2: Identification of alkylamides in an ethanolic extract of S. acmella. 
 
 
 
 
# 
 
 
Compound Name 
 
MH+ 
(m/z) 
Retention 
Time 
(min) 
1 (2Z)-N-isobutyl-2-nonene-6,8-diynamide 204.1 2.27 
2 (2E)-N-isobutyl-2-undecene-8,10-diynamide 232.1 3.50 
3 (2E,6Z,8E)-N-isobutyl-2,6,8-decatrienamide (spilanthol) 222.2 4.33 
4 (2E)-N-(2-methylbutyl)-2-undecene-8,10-diynamide 246.1 5.04 
5 (2E,7Z)-N-isobutyl-2,7-tridecadiene-10,12-diynamide 258.1 5.54 
6 (2E,6Z,8E)-N-(2-methylbutyl)-2,6,8-decatrienamide 236.3 6.22 
7 (7Z)-N-isobutyl-7-tridecene-10,12-diynamide 260.0 6.28 
8 (2E,4Z)-N-isobutyl-2,4-undecadiene-8,10-diynamide 230.0 2.92 
9 (2E,4E,8Z,10E)-N-isobutyl-dodeca-2,4,8,10-tetraenamide 248.1 7.76 
10 (2Z)-N-phenethyl-2-nonene-6,8-diynamide* 252.2 3.36 
11 N-phenethyl-2,3-epoxy-6,8-nonadiynamide* 268.0 2.35 
*Compounds were only identified based on molecular ion values, MS-MS fragmentation patterns were not 
consistent with expected fragments. 
 
 
 
Further validation of correct structural assignment was provided by MS-MS 
analysis.  The MS-MS fragments (obtained with collisionally activated dissociation in the 
ion trap) for compounds 1-2 and 3-9 are shown the Figures 21-28.  The structure of the 
protonated molecular ion and assignment of fragments is also shown.  Alkylamides have 
previously been shown to fragment at both sides of the C-N bond35 when subjected to 
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collisionally induced dissociation, and MS-MS spectra of nine alkylamides (compounds 
1-9) showed fragments consistent with dissociation at these positions.  The molecular ion 
masses of compounds 1-7 and 10-11 matched published molecular weight of nine 
alkylamides that have previously been confirmed as components of S. acmella.3, 11  The 
molecular ion of compound 8 matched the molecular weight of the alkylamide (2E,4Z)-
N-isobutyl-2,4-undecadiene-8,10-diynamide, that has been reported in S. ciliata22, 23 and 
S. alba,19 although no reports of this compound in S. acmella have been published thus 
far.  Compound 9 has a molecular ion that matches published data for (2E,4E,8Z,10E)-N-
isobutyl-dodeca-2,4,8,10-tetraenamide found in S. mauritiana,21 S. oppositifolia,26 S. 
ciliate,22, 23 and S. alba,19 but not in S. acmella.  Both (2E,4Z)-N-isobutyl-2,4-
undecadiene-8,10-diynamide (tentative identification of compound 8) and 
(2E,4E,8Z,10E)-N-isobutyl-dodeca-2,4,8,10-tetraenamide (tentative identification of 
compound 9) have previously been identified in Echinacea purpurea.  The MS-MS 
spectra of compounds 8 and 9 match published MS-MS data for (2E,4Z)-N-isobutyl-2,4-
undecadiene-8,10-diynamide and (2E,4E,8Z,10E)-N-isobutyl-dodeca-2,4,8,10-
tetraenamide, respectively, in Echinacea purpurea.35  Compounds 10 and 11 gave only 
very small signals in the base peak chromatogram and their MS-MS fragmentation 
patterns did not show the expected fragments that would be produced by dissociation of 
the C-N bonds within the molecule.  The discrepancy of the MS-MS fragmentation may 
be due to mis-identification of the molecular ion.  It is also likely that the presence of the 
phenyl group instead of the isobutyl or 2-methylbutyl group attached to the amide 
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nitrogen results in a different fragmentation pattern than has been observed previously for 
2-methylbutyl and isobutylamides.   
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Figure 21: MS-MS spectrum obtained by activated dissociation with a collision 
energy of 35% of protonated molecular ion for (2Z)-N-isobutyl-2-nonene-6,8-
diynamide at m/z 204.  
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Figure 22: MS-MS spectrum obtained by activated dissociation with a collision 
energy of 35% of protonated molecular ion for (2E)-N-isobutyl-2-undecene-8,10-
diynamide at m/z 232. 
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Figure 23: MS-MS spectrum obtained by activated dissociation with a collision 
energy of 35% of protonated molecular ion for (2E)-N-(2-methylbutyl)-2-undecene-
8,10-diynamide at m/z 246. 
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Figure 24: MS-MS spectrum obtained by activated dissociation with a collision 
energy of 35% of protonated molecular ion for (2E,7Z)-N-isobutyl-2,7-tridecadiene-
10,12-diynamide at m/z 258. 
 
 
Spilanthes-MSMS #393-429 RT: 6.18-6.61 AV: 17 NL: 1.46E6
F: + c ESI d Full ms2 258.06@35.00 [ 60.00-270.00]
60 80 100 120 140 160 180 200 220 240 260
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
el
at
iv
e 
A
bu
nd
an
ce
202.11
117.12
157.10131.11
129.14
159.09
185.09
143.10
105.10 161.04 230.1391.09
174.16
216.16
93.07 187.1179.06 204.04 240.10 258.18
77.05 265.77
N
H
OH
202131 157 
187 
 
48 
 
 
 
Figure 25: MS-MS spectrum obtained by activated dissociation with a collision 
energy of 35% of protonated molecular ion for (2E,6Z,8E)-N-(2-methylbutyl)-2,6,8-
decatrienamide at m/z 236. 
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Figure 26: MS-MS spectrum obtained by activated dissociation with a collision 
energy of 35% of protonated molecular ion for (7Z)-N-isobutyl-7-tridecene-10,12-
diynamide at m/z 260. 
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Figure 27: MS-MS spectrum obtained by activated dissociation with a collision 
energy of 35%of protonated molecular ion for (2E,4Z)-N-isobutyl-2,4-undecadiene-
8,10-diynamide at m/z 230. 
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Figure 28: MS-MS spectrum obtained by activated dissociation with a collision 
energy of 35%of protonated molecular ion for (2E,4E,8Z,10E)-N-isobutyl-dodeca-
2,4,8,10-tetraenamide at m/z 248. 
 
 
 
The stereochemistry of spilanthol was confirmed using 1H-NMR and 13C-NMR.  
The shifts observed for the isolated spilanthol with 1H-NMR and 13C NMR matched 
previously published values 11 for spilanthol and are as follows: 1H-NMR (CDCl3, 500 
MHz), δ 6.82 (dt, 1H, J=15Hz), 6.28 (br dd, 1H, J=15Hz), 5.97 (dd, 1H, J=11Hz), 5.77 
(br d, 1H, J=15Hz), 5.69 (dq, 1H, J=15Hz), 5.26 (dt, 1H, J=11Hz), 3.14 (dd, 2H), 2.29 
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(m, 4H), 1.77 (m, 1H), 1.77 (d, 3H), 0.92 (d, 6H).  13C NMR (CDCl3, 125 MHz) δ 
166.06, 143.78, 130.10, 129.52, 127.79, 126.77, 124.13, 46.92, 32.19, 28.68, 26.44, 
20.22, 18.44.  The 1H-NMR and 13C NMR spectra can be seen in Figures 29 - 34. 
 
 
 
 
Figure 29: 1H-NMR spectra for spilanthol (CDCl3, 500 MHz).
53 
 
 
 
 
 
Figure 30: 1H-NMR of spilanthol zoomed in from 0.8-3.2 ppm (CDCl3, 500 MHz). 
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Figure 31: 1H-NMR of spilanthol zoomed in from 5.2-7.3 ppm (CDCl3, 500 MHz).
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Figure 32: 13C-NMR for spilanthol (CDCl3, 125 MHz). 
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Figure 33: 13C-NMR for spilanthol zoomed in from 16-50 ppm (CDCl3, 125 MHz).
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Figure 34: 13C-NMR for spilanthol zoomed in from 122-166 ppm (CDCl3, 125 MHz). 
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Method Validation 
The stock solution of spilanthol (isolated from S. acmella as described previously) 
was serially diluted to make five standards at concentrations of 1.4 µM, 4.5 µM, 14 µM, 
45 µM, and 140 µM.  The calibration standards were analyzed using HPLC/ESI-MS as 
described earlier.  A calibration was generated by plotting the log of the sum of the peak 
areas of the selected ion chromatograms for the spilanthol ions versus the log of the 
concentration.  Because spilanthol forms a dimer in the gas phase, the peak area for m/z 
443 (proton bound dimer) was doubled and added to the peak area of m/z 222 (protonated 
molecular ion) to account for all of the spilanthol response.  Figure 35 shows a calibration 
curve for spilanthol.  The correlation coefficient, y-intercept, slope of regression line and 
plot were evaluated and the results can be seen in Table 3.  LOD and LOQ were 
determined based on signal to noise ratio of 3:1 and 10:1 respectively and are also 
presented in Table 3. 
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Figure 35: Calibration curve for spilanthol. 
 
 
 
Table 3: Regression parameters, detection limit, and quantification limit.  These 
calculations were based upon triplicate analyses of five standard solutions of 
spilanthol.  The MDL and MQL were determined based on signal-to-noise ratios of 
3:1 and 10:1 respectively, with the noise determined from injection of a solvent 
blank (95% ethanol.) 
 
 
Validation Parameter Result 
Correlation Coefficient 0.9965 
y-intercept 7.69 ± 0.02 
Slope of regression line 1.01 ± 0.02 
Number of data points 15 
Range 0.45µM to 450 µM 
Limit of Detection 0.27 µM 
Limit of Quantitation 0.45 µM 
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Figure 36 shows representative selected ion chromatograms used in determining LOD 
and LOQ.  Due to poor synchronization between the mass spectrometer and the HPLC, 
the retention times do not line up in the figure.   
 
 
 
 
Figure 36: Selected ion chromatograms of spilanthol standards used to determine 
LOQ and LOD. 
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The results of the studies that were conducted to evaluate precision are shown in 
Table 4.  The %RSD values for both repeatability and intermediate precision were less 
than 6%, showing excellent reproducibility of the method.  Precision data was obtained 
from analyzing five standards in triplicate over three days.  The repeatability was 
determined within a day and intermediate precision was calculated using the average 
back calculated concentration per day and determining the % relative standard deviation.  
The % residuals were determined form the intermediate precision average of each 
concentration. 
 
 
Table 4: Precision Data 
 
 
Theoretical 
Concentration 
(µg/mL) 
Measured 
Concentration 
(µg/mL) Residuals (%) 
Repeatability 
(%) 
Intermediate 
Precision 
(%) 
0.3 0.3 -8% 6% 2% 
1.0 1.1 7% 4% 2% 
3.2 3.3 5% 2% 1% 
10.0 9.8 -2% 1% 1% 
31.6 30.7 -3% 6% 1% 
 
 
 
Antibacterial Assays 
The antibacterial activity was tested by the agar diffusion method with top agar.  
A sample that shows antibacterial activity will inhibit the growth of bacteria around the 
disk containing the sample.  The size of the inhibition zone is not directly indicative of 
the antibacterial strength of the compound due to several reasons: not all compounds will 
have the same rate of diffusion through the agar, the plates do not have exactly the same 
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concentration of bacteria, and the disks containing the sample may not have the same 
concentrations.  Figure 37 shows kanamycin (30µg), a known antibiotic, used as the 
positive control in these experiments.  There is a distinct zone of inhibition around the 
disk containing the antibiotic which indicates the absence or inhibition of growth of 
bacteria.  The spilanthol, neat Spilanthes extract, and 10x concentrated extract tests 
showed no zone of inhibition and, hence, no antibacterial activity at that concentration 
against Staphylococcus aureus.  The same samples were also tested with 5mg/mL 
berberine and showed no additional inhibition beyond the berberine control.  All tests 
were done in triplicate and Figures 38 and 39 show one replicate of the assay for each 
sample tested. 
 
 
 
Figure 37: Antibacterial assay results for 30µg kanamycin antibiotic disks in 
duplicate. 
Kanamycin 30µg Control 
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Figure 38: Antibacterial assay results for spilanthol a) without berberine b) with 
berberine. 
 
 
 
 
 
 
Figure 39: Antibacterial assay results for Spilanthes extract a) without berberine b) 
with berberine. 
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CHAPTER IV 
 
 
CONCLUSIONS  
 
 
 
Summary and Significance 
A rapid and simple reversed-phase HPLC/ESI-MS method was developed and 
validated according to ICH guidelines for the simultaneous identification and 
quantification of spilanthol in ethanolic extracts of S. acmella.  This is the first example 
of the use of electrospray ionization rather than electron impact ionization for 
determination of Spilanthes alkylamides.  The use of this soft ionization technique 
coupled to a mass spectrometer with an ion trap mass analyzer enables the identification 
of the molecular ion and the collection of MS-MS spectra.  Our studies demonstrate that 
such MS-MS spectra can be very useful for identification of alkylamides in complex 
Spilanthes extracts. 
The ability to interface directly to HPLC separations is another advantage of this 
new method analysis.  On-line HPLC-MS analysis facilitates the rapid determination of 
alkylamide content in the same ethanolic extracts of Spilanthes that are typically used by 
consumers.  To date, there have been no published methods for quantification of 
alkylamides in ethanolic Spilanthes extracts.  By demonstrating an approach to 
quantitatively determine spilanthol concentration in Spilanthes extracts, the method 
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published here will facilitate further assessment of the biological benefits and risks of 
therapeutic use of Spilanthes. 
The method developed during this research enabled tentative identification (based on 
molecular weight and fragmentation patterns) of six alkylamides previously identified in 
S. acmella and two additional alkylamides not previously identified in S. acmella.  The 
alkylamides tentatively identified in S. acmella were as follows: (2Z)-N-isobutyl-2-
nonene-6,8-diynamide, (2E)-N-isobutyl-2-undecene-8,10-diynamide, (2E)-N-(2-
methylbutyl)-2-undecene-8,10-diynamide, (2E,7Z)-N-isobutyl-2,7-tridecadiene-10,12-
diynamide, (2E,6Z,8E)-N-(2-methylbutyl)-2,6,8-decatrienamide, (7Z)-N-isobutyl-7-
tridecene-10,12-diynamide, (2E,4Z)-N-isobutyl-2,4-undecadiene-8,10-diynamide, 
(2E,4E,8Z,10E)-N-isobutyl-dodeca-2,4,8,10-tetraenamide.  The structure of the most 
abundant of these alkylamides, (2E,6Z,8E)-N-isobutyl-2,6,8-decatrienamide (spilanthol), 
was confirmed by NMR.   
The investigations published here also demonstrate for the first time the stability of 
spilanthol in an ethanolic extract.  For the 75% ethanolic extract of fresh whole plants of 
S. acmella, there was no significant degradation of spilanthol (at least none detectable 
beyond the scatter of the data) during storage over six and a half months at room 
temperature, -20°C, and -80°C.  These results indicate that alkylamide constituents of S. 
acmella extracts can be tested for biological activity over a time period of at least six 
months without concern about major degradation of alkylamides.   
Complex S. acmella extract and isolated spilanthol showed no antibacterial activity 
against Staphylococcus aureus; nor did they show activity in combination with berberine.  
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Thus, spilanthol appears not to be useful against Staphylococcus aureus or as a synergist 
to enhance the antibacterial activity of berberine against this bacterium.  These results are 
consistent with literature reports which report no activity against Staphylococcus aureus.  
Another study investigated Spilanthes mauritiana and reported that it demonstrates very 
low antibacterial activity against 105 strains of bacteria.  Spilanthes is traditionally used 
to treat mouth sores and sore throats; this may be due to the analgesic action of the 
alkylamide constituents rather than any antibacterial activity.   
Future Research 
To broaden the scope of the method published here, isolation and positive 
identification of more alkylamides would be useful.  Once the alkylamides are isolated, 
NMR analysis can confirm the identification that has been based so far solely on mass 
spectrometric data.  The isolated alkylamides can then be used to create standards and 
facilitate quantification of additional constituents in Spilanthes.  
Another aspect that can be investigated in addition to this research is structure of the 
alkylamides tentatively identified as (2Z)-N-phenethyl-2-nonene-6,8-diynamide and N-
phenethyl-2,3-epoxy-6,8-nonadiynamide.  Their MS-MS fragmentation patterns did not 
show the expected fragments that would be produced by dissociation of the C-N bonds 
within the molecule which may be due to mis-identification of the molecular ion or the 
presence of the phenyl group instead of the isobutyl or 2-methylbutly group attached to 
the amide nitrogen.  By comparing NMR data and MS-MS fragmentation patterns, the 
identity of these two alkylamides could be discerned.   
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